trending Market Intelligence /marketintelligence/en/news-insights/trending/EDWE19yuF7ZgHTN0QPdoyw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Palla Pharma to raise A$31.1M in placement, entitlement offer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Palla Pharma to raise A$31.1M in placement, entitlement offer

Palla Pharma Ltd. is planning to raise a total of A$31.1 million in a capital raising consisting of a placement and an entitlement offer.

The capital raising is priced at 70 Australian cents per share.

The placement offer is expected to raise about A$8.4 million, while the entitlement offer is expected to raise approximately $22.7 million.

Eligible shareholders can subscribe for 2 new ordinary shares of the company for every 5 existing shares they hold Oct. 21 under the entitlement offer. The entitlement offer comprises an institutional component and a retail component.

Eligible institutional shareholders can participate in the placement and the institutional entitlement offer, which will take place from Oct. 17 to Nov. 18. The institutional shareholders can also decide to take up all, part or none of their entitlements, which cannot be traded on the market.

Meanwhile, eligible retail shareholders can participate in the retail component of the entitlement offer at 70 cents per share. The retail component opens Oct. 23 and will close Nov. 11.

Arnold Bloch Leibler and KPMG advised Palla Pharma on the capital raising. Morgans Corporate Ltd. and Shaw and Partners Ltd. are joint lead-managers and underwriters.

The retail entitlement offer is also underwritten by Morgans Corporate Ltd. and Shaw and Partners Ltd.

Australia's Palla Pharma produces and distributes narcotic raw materials, active pharmaceutical ingredients and finished dosage formulations for pharmaceutical markets.